|
China Health Industries Holdings Inc (NONE: CHHE) |
|
China Health Industries Holdings Inc
CHHE's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
China Health Industries Holdings Inc 's sales fell
by -99.59 % in the third quarter of 2024 from the same quarter a year ago.
Ranking at No. 300
Major Pharmaceutical Preparations industry recorded
growth of revenues by 0.35 %
China Health Industries Holdings Inc net loss decreased from $0 millions, to $0 millions in third quarter of 2024,
• More on CHHE's Growth
|
|
China Health Industries Holdings Inc realized a net loss in trailing twelve months.
China Health Industries Holdings Inc realized cash reduction of $ -0.66 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1055.56.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.
• More on CHHE's Valuation
|
|
|
|
|
China Health Industries Holdings Inc realized net loss in trailing twelve months.
China Health Industries Holdings Inc realized cash outflow of $ -0.66per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 1055.56.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.
• More on CHHE's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com